Migrate Health

First cited by AI Oct 27, 2026migratehealth.com ↗

Surfaced organically in AI answers about compounded glp-1s. Not yet profiled.

#18 of 47 in Compounded GLP-1s

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning Migrate Health, through Oct 28, 2026.

5.3%

Avg position when mentioned: 4.0 · peak 8% on Oct 27

By engine

Where Migrate Health is strong, and where it is invisible.

Claude
11.1%

Mention sentiment

Tone of AI mentions across all tracked answers.

1 positive mentions
0 neutral
0 mixed or cautious

Recent AI answers mentioning Migrate Health

ClaudeOct 27, 2026, 21:03 UTC

My insurance denied Wegovy. Are compounded GLP-1s my best option?

This is a common situation right now. Here are your realistic options: Compounded GLP-1s (Your Question) Yes, they're worth considering, but with caveats: Hims & Hers, Ro, and LifeMD offer compounded semaglutide online Significantly cheaper (~$200-400/month vs. $1,300+ for Wegovy) Important caveat: FDA has flagged quality concerns with some compounders, and compounded versions aren't FDA-approved. The FDA recently declared the semaglutide shortage over, which may affect legal availability of compounded versions soon. Other Options to Consider First Appeal your denial: Migrate Health or your own doctor can help with prior authorization appeals - success rates are meaningful Manufacturer savings: Novo Nordisk's savings card can reduce Wegovy to ~$650/month if you have commercial insurance (not Medicare/Medicaid) Alternative FDA-approved medications: Zepbound (tirzepatide) - sometimes approved when Wegovy isn't Qsymia or Contrave - older, cheaper, less effective but insurance-friendly Cost-plus pharmacies: Cost Plus Drugs (Mark Cuban's) carries some weight loss medications at reduced prices My Honest Take Try appealing and check Zepbound eligibility before going compounded. If those fail, reputable compounders like Ro are a reasonable bridge. Talk to your doctor about the best path for your specific situation.

Mentioned in position 4 of 6

Read full answer with sources →

TL;DR

Migrate Health is a telehealth platform focused on weight management, best known for connecting patients with compounded GLP-1 medications. It operates in a crowded direct-to-consumer space and currently ranks 14th in WellRank's Compounded GLP-1s category with 8% AI visibility, appearing alongside established names such as Ro, LifeMD, and Hims & Hers in AI-generated answers.

Company Overview

Migrate Health, accessible at migratehealth.com, is a direct-to-consumer telehealth company centered on obesity and weight-loss care. Its business model follows the subscription-style, online-consult-to-prescription pattern common in the telehealth sector, connecting patients with licensed clinicians who can prescribe compounded GLP-1 therapies. Founding details, headquarters location, and leadership team are not publicly disclosed in widely available sources.

Product Features

Online clinical consultations for weight-loss medication eligibility
Access to compounded GLP-1 injectable medications
Ongoing prescription management through a telehealth platform
Asynchronous or virtual provider communication
Home delivery of prescribed medications

Target Market

Migrate Health primarily serves adults in the United States who are seeking medical weight management, particularly those interested in GLP-1 receptor agonist therapies. The platform targets patients who may face cost or access barriers to brand-name medications and prefer the convenience of an online care model.

Buyer Personas

A cost-conscious adult with obesity who cannot afford brand-name Ozempic or Wegovy and is exploring compounded alternatives through telehealth.
A busy professional who wants a fully online process, from consultation to home delivery, with no in-person clinic visits.
A patient whose insurance does not cover GLP-1 medications and who is researching out-of-pocket telehealth options.
Someone who has already begun a GLP-1 regimen elsewhere and is comparison-shopping for a more affordable ongoing provider.

Funding & Performance

Funding stage, investor backing, and revenue figures for Migrate Health are not publicly disclosed. The company does not appear to have announced a public financing round in widely available sources.

Recent Developments

Migrate Health has gained organic visibility in AI-generated answers about compounded GLP-1s, suggesting growing search and citation traction in a category that expanded rapidly following widespread interest in semaglutide and tirzepatide. The broader compounded GLP-1 telehealth sector has faced evolving FDA guidance on compounded medications, and how Migrate Health is navigating that regulatory environment is not publicly detailed.

Competitive Landscape

According to WellRank's co-mention data, AI engines most frequently name Migrate Health alongside Ro, LifeMD, Hims & Hers, Novo Nordisk, and Cost Plus Drugs when answering questions about compounded GLP-1s. Ro and LifeMD are well-funded telehealth incumbents with established weight-loss programs, while Hims & Hers has a large consumer brand presence, making differentiation on price, access, or patient experience the likely competitive lever for a newer entrant like Migrate Health.

Migrate Health vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

Brand	Rank	AI visibility	Avg position	Sentiment
Migrate HealthThis brand	#18	5.3%	4.0	positive85
Cost Plus Drugs 1 shared answers	#12	10.5%	3.5	positive78
Hims & Hers 1 shared answers	#1	63.2%	2.1	positive75
LifeMD 1 shared answers	#4	31.6%	3.5	positive71
Novo Nordisk 1 shared answers	#3	47.4%	4.4	positive66

Email me when overtakes Migrate Health

One email the day the ranks flip. Nothing else.

User Sentiment

Within WellRank's current corpus, Migrate Health's single recorded AI mention carries a positive tone, with no neutral or cautious mentions logged. Because the sample size is very small, this signal should be read as directionally encouraging rather than conclusive, and broader public review sentiment is not yet available in widely indexed sources.

Pricing

Pricing details for consultations and medication plans are not published in widely available sources and should be confirmed directly on the platform, as compounded GLP-1 pricing in telehealth varies by dose, quantity, and whether ongoing membership fees apply.

Sources cited around Migrate Health

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Migrate Health weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Migrate Health? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.